Ripple Spent Nearly Billion on Deals to Build XRP Rails
Ripple has spent close to $3 billion on acquisitions since 2023 to build out institutional rails. The moves aim to em...
Ways To Treat Yourself After Budgeting Wins
Treating yourself after wins reinforces positive budgeting. Learn Ways To Treat Yourself After Budgeting Wins with simple, meaningful rewards that align with goals.
21,818 articles
Just Four Dividend Stocks Power $2K Monthly Retirement
A focused four-stock approach could turn a $400,000 investment into roughly $2,000–$2,500 a month in retirement incom...
Investors Learn AI Prompting to Beat Market Returns
Investors are turning to AI prompting to translate complex data into sharper bets as markets rise in early 2026. Expe...
Feds Seize Million Tether Linked to Pig-Butchering Scams
Federal investigators have seized over $61 million in USDT linked to romance scam operations, tracing the funds throu...
XRP Price Prediction Sparks Cardano Founder Remarks
Regulatory rhetoric around the Clarity Act ignites a fresh XRP debate, with Cardano founder Charles Hoskinson warning...
Investors This Have Earned More with This ETF Strategy
A disciplined, theme-driven ETF approach can produce returns that exceed typical expectations. Learn how to recognize...
Can XRP Price Reach $10? Here’s What It Would Take
As XRP trades near $1.43, analysts weigh whether a $10 price is possible and outline the five catalysts and macro con...
Asked ChatGPT Indeed $48: XRP Price Target Sparks Debate
A bold XRP price target sparked renewed debate after a viral prompt. AI analysis shows the path to $48 hinges on a ra...
Paypal Expands PYUSD Stablecoin Across 70 Markets Globally
PayPal is extending the reach of its USD-backed PYUSD stablecoin to 70 international markets. With PYUSD supply surpa...
Ripple-Backed Company Holding XRP Treasury Eyes Nasdaq IPO
Evernorth Holdings, a Ripple-backed company holding 473 million XRP, filed an S-4 to go public on Nasdaq through a $1...
Figma's Stock Trading Like AI Buzz: Is Risk Misread?
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status